# Effects of PTH Replacement on Bone in Hypoparathyroidism

> **NCT00395538** · PHASE3 · TERMINATED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 46 (actual)

## Conditions studied

- Hypoparathyroidism
- DiGeorge Syndrome

## Interventions

- **DRUG:** PTH 1-34

## Key facts

- **NCT ID:** NCT00395538
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10-30
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-10-04
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Pharmacy temporarily suspended by FDA
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395538, "Effects of PTH Replacement on Bone in Hypoparathyroidism". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00395538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*